Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Inhibition of SHIP2 activity inhibits cell migration and could prevent metastasis in breast cancer cells

S. Ghosh, S. Scozzaro, AR. Ramos, S. Delcambre, C. Chevalier, P. Krejci, C. Erneux,

. 2018 ; 131 (16) : . [pub] 20180816

Jazyk angličtina Země Velká Británie

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc19045363

Metastasis of breast cancer cells to distant organs is responsible for ∼50% of breast cancer-related deaths in women worldwide. SHIP2 (also known as INPPL1) is a phosphoinositide 5-phosphatase for phosphatidylinositol (3,4,5)-trisphosphate [PI(3,4,5)P3] and phosphatidylinositol (4,5)-bisphosphate [PI(4,5)P2]. Here we show, through depletion of SHIP2 in triple negative MDA-MB-231 cells and the use of SHIP2 inhibitors, that cell migration appears to be positively controlled by SHIP2. The effect of SHIP2 on migration, as observed in MDA-MB-231 cells, appears to be mediated by PI(3,4)P2. Adhesion on fibronectin is always increased in SHIP2-depleted cells. Apoptosis measured in MDA-MB-231 cells is also increased in SHIP2-depleted cells as compared to control cells. In xenograft mice, SHIP2-depleted MDA-MB-231 cells form significantly smaller tumors than those formed by control cells and less metastasis is detected in lung sections. Our data reveal a general role for SHIP2 in the control of cell migration in breast cancer cells and a second messenger role for PI(3,4)P2 in the migration mechanism. In MDA-MB-231 cells, SHIP2 has a function in apoptosis in cells incubated in vitro and in mouse tumor-derived cells, which could account for its role on tumor growth determined in vivo.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19045363
003      
CZ-PrNML
005      
20200115082421.0
007      
ta
008      
200109s2018 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1242/jcs.216408 $2 doi
035    __
$a (PubMed)30012834
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Ghosh, Somadri $u IRIBHM, Campus Erasme, ULB Bâtiment C, 808 route de Lennik, 1070 Bruxelles, Belgium.
245    10
$a Inhibition of SHIP2 activity inhibits cell migration and could prevent metastasis in breast cancer cells / $c S. Ghosh, S. Scozzaro, AR. Ramos, S. Delcambre, C. Chevalier, P. Krejci, C. Erneux,
520    9_
$a Metastasis of breast cancer cells to distant organs is responsible for ∼50% of breast cancer-related deaths in women worldwide. SHIP2 (also known as INPPL1) is a phosphoinositide 5-phosphatase for phosphatidylinositol (3,4,5)-trisphosphate [PI(3,4,5)P3] and phosphatidylinositol (4,5)-bisphosphate [PI(4,5)P2]. Here we show, through depletion of SHIP2 in triple negative MDA-MB-231 cells and the use of SHIP2 inhibitors, that cell migration appears to be positively controlled by SHIP2. The effect of SHIP2 on migration, as observed in MDA-MB-231 cells, appears to be mediated by PI(3,4)P2. Adhesion on fibronectin is always increased in SHIP2-depleted cells. Apoptosis measured in MDA-MB-231 cells is also increased in SHIP2-depleted cells as compared to control cells. In xenograft mice, SHIP2-depleted MDA-MB-231 cells form significantly smaller tumors than those formed by control cells and less metastasis is detected in lung sections. Our data reveal a general role for SHIP2 in the control of cell migration in breast cancer cells and a second messenger role for PI(3,4)P2 in the migration mechanism. In MDA-MB-231 cells, SHIP2 has a function in apoptosis in cells incubated in vitro and in mouse tumor-derived cells, which could account for its role on tumor growth determined in vivo.
650    _2
$a zvířata $7 D000818
650    _2
$a protinádorové látky $x farmakologie $7 D000970
650    _2
$a nádory prsu $x patologie $7 D001943
650    _2
$a pohyb buněk $x účinky léků $x genetika $7 D002465
650    _2
$a inhibitory enzymů $x farmakologie $7 D004791
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a MFC-7 buňky $7 D061986
650    _2
$a myši $7 D051379
650    _2
$a myši inbrední NOD $7 D016688
650    _2
$a myši SCID $7 D016513
650    _2
$a metastázy nádorů $7 D009362
650    _2
$a fosfatidylinositol-3,4,5-trisfosfát-5-fosfatasy $x antagonisté a inhibitory $x genetika $x metabolismus $7 D000072183
650    _2
$a nádorové buňky kultivované $7 D014407
650    _2
$a xenogenní modely - testy protinádorové aktivity $7 D023041
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Scozzaro, Samuel $u IRIBHM, Campus Erasme, ULB Bâtiment C, 808 route de Lennik, 1070 Bruxelles, Belgium.
700    1_
$a Ramos, Ana Raquel $u IRIBHM, Campus Erasme, ULB Bâtiment C, 808 route de Lennik, 1070 Bruxelles, Belgium.
700    1_
$a Delcambre, Sébastien $u Stem cell and Cancer group, ULB Campus Erasme, 1070 Brussels, Belgium.
700    1_
$a Chevalier, Clément $u Center for Microscopy and Molecular Imaging ULB, 12 rue des professeurs Jeener et Brachet, 6041 Charleroi, Belgium.
700    1_
$a Krejci, Pavel $u Department of Biology, Faculty of Medicine, Masaryk University, 62500 Brno, Czech Republic. International Clinical Research Center, St. Anne's University Hospital, 65691 Brno, Czech Republic.
700    1_
$a Erneux, Christophe $u IRIBHM, Campus Erasme, ULB Bâtiment C, 808 route de Lennik, 1070 Bruxelles, Belgium cerneux@ulb.ac.be.
773    0_
$w MED00002576 $t Journal of cell science $x 1477-9137 $g Roč. 131, č. 16 (2018)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/30012834 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20200109 $b ABA008
991    __
$a 20200115082754 $b ABA008
999    __
$a ok $b bmc $g 1483632 $s 1084036
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2018 $b 131 $c 16 $e 20180816 $i 1477-9137 $m Journal of cell science $n J Cell Sci $x MED00002576
LZP    __
$a Pubmed-20200109

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace